These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 1345409

  • 1. Controlled comparison of RO 11-1163 (moclobemide) and placebo in the treatment of depression.
    Botte L, Evrard JL, Gilles C, Stenier P, Wolfrum C.
    Acta Psychiatr Belg; 1992; 92(6):355-69. PubMed ID: 1345409
    [Abstract] [Full Text] [Related]

  • 2. A double-blind placebo-controlled comparison of moclobemide and amitriptyline in the treatment of depression.
    Bakish D, Wiens A, Ellis J, Alda M, Lapierre Y.
    Can J Psychiatry; 1992 Sep; 37 Suppl 1():12-7. PubMed ID: 1394026
    [Abstract] [Full Text] [Related]

  • 3. Moclobemide, imipramine, and placebo in the treatment of major depression (DSM III).
    Versiani M, Nardi AE, Mundim FD, Alves AB.
    J Neural Transm Suppl; 1989 Sep; 28():65-75. PubMed ID: 2794994
    [Abstract] [Full Text] [Related]

  • 4. Moclobemide versus fluoxetine in the treatment of major depressive disorder in adults.
    Lapierre YD, Joffe R, McKenna K, Bland R, Kennedy S, Ingram P, Reesal R, Rickhi BG, Beauclair L, Chouinard G, Annable L.
    J Psychiatry Neurosci; 1997 Mar; 22(2):118-26. PubMed ID: 9074306
    [Abstract] [Full Text] [Related]

  • 5. A controlled double-blind trial of moclobemide and imipramine in the treatment of depression.
    Kok LP, Tsoi WF.
    Singapore Med J; 1995 Feb; 36(1):38-40. PubMed ID: 7570133
    [Abstract] [Full Text] [Related]

  • 6. Moclobemide and sertraline in the treatment of depressive disorders: a comparative study.
    Orsel Donbak S, Turkçapar MH, Ozturk Kiliç EZ, Demirergi N, Akdemir A, Sirin A, Ozbay MH.
    Acta Psychiatr Belg; 1995 Feb; 95(3):139-51. PubMed ID: 8525856
    [Abstract] [Full Text] [Related]

  • 7. Thyroid functioning during treatment for depression.
    Kusalic M, Engelsmann F, Bradwejn J.
    J Psychiatry Neurosci; 1993 Nov; 18(5):260-3. PubMed ID: 8297924
    [Abstract] [Full Text] [Related]

  • 8. Combination therapy using moclobemide with tricyclic and tetracyclic antidepressants to treat therapy-resistant depression.
    König F, Wolfersdorf M.
    Pharmacopsychiatry; 1997 May; 30(3):93-6. PubMed ID: 9211570
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 10. Double-blind comparison of moclobemide, imipramine and placebo in depressive patients.
    Ucha Udabe R, Márquez CA, Traballi CA, Portes N.
    Acta Psychiatr Scand Suppl; 1990 Feb; 360():54-6. PubMed ID: 2123367
    [Abstract] [Full Text] [Related]

  • 11. Double-blind comparison of moclobemide and tranylcypromine in depression.
    Heinze G, Rossel L, Gabelic I, Galeano-Munoz J, Stabl M, Allen SR.
    Pharmacopsychiatry; 1993 Nov; 26(6):240-5. PubMed ID: 8127928
    [Abstract] [Full Text] [Related]

  • 12. Moclobemide versus placebo in the treatment of depression: a multicentre study in Belgium.
    Botte L, Gilles C, Evrard JL, Mesters P, Wolfrum C, Berger M, Hellstern K, Ward J.
    Acta Psychiatr Scand Suppl; 1990 Nov; 360():42. PubMed ID: 2248066
    [Abstract] [Full Text] [Related]

  • 13. Moclobemide versus imipramine in depressed out-patients: a double-blind multi-centre study.
    Rimón R, Jääskeläinen J, Kaartinen P, Kalli A, Kilponen E, Koskinen T, Nikkilä H, Pirttiperä V, Seppälä J.
    Int Clin Psychopharmacol; 1993 Jan; 7(3-4):141-7. PubMed ID: 8468435
    [Abstract] [Full Text] [Related]

  • 14. Moclobemide, imipramine and placebo in the treatment of major depression.
    Versiani M, Nardi AE, Mundim FD, Alves A, Schmid-Burgk W.
    Acta Psychiatr Scand Suppl; 1990 Jan; 360():57-8. PubMed ID: 2248073
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of moclobemide compared with maprotiline in treatment of major depressive disorder. A double-blind multicenter study with parallel groups.
    Steinmeyer EM, Vorbach EU, Arnoldt KH.
    Pharmacopsychiatry; 1993 Nov; 26(6):246-53. PubMed ID: 8127929
    [Abstract] [Full Text] [Related]

  • 16. Moclobemide versus clomipramine in the treatment of depression: a multicentre trial in Spain.
    Civeira J, Cervera S, Giner J, Allen SR, Hellstern K, Malanowski H, Wirz R, Klar K.
    Acta Psychiatr Scand Suppl; 1990 Nov; 360():48-9. PubMed ID: 2248070
    [Abstract] [Full Text] [Related]

  • 17. Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial. International Collaborative Study Group.
    Versiani M, Amrein R, Stabl M.
    Int Clin Psychopharmacol; 1997 Jul; 12(4):183-93. PubMed ID: 9347378
    [Abstract] [Full Text] [Related]

  • 18. Moclobemide versus clomipramine in the treatment of depression: a double-blind multicentre study in Belgium.
    Dierick M, Cattiez P, Franck G, Burton P, Defleur J, Hermans W, Roelandts A, Wolfrum C, Berger M, Hellstern K.
    Acta Psychiatr Scand Suppl; 1990 Jul; 360():50-1. PubMed ID: 2248071
    [Abstract] [Full Text] [Related]

  • 19. Moclobemide (Ro 11-1163) versus desipramine in the treatment of endogenous depression.
    Gabelic I, Moll E.
    Acta Psychiatr Scand Suppl; 1990 Jul; 360():44-5. PubMed ID: 2248068
    [Abstract] [Full Text] [Related]

  • 20. Moclobemide (Ro 11-1163) versus imipramine in the treatment of depression.
    Casacchia M, Moll E.
    Acta Psychiatr Scand Suppl; 1990 Jul; 360():43. PubMed ID: 2248067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.